TABLE 1.
Drug | Dose (mg/kg/day) | Delivery route | No. of survivorsa | Organ load (CFU/g of tissue)e
|
|
---|---|---|---|---|---|
Kidneys | Lungs | ||||
Trial 1 | |||||
Controlb | 0 | PO | 0 | 110 ± 18 × 105 | 204 ± 45 × 102 |
DAMB | 2 | IP | 10 | 20 ± 4 × 102 | 0 |
CAMB | 0.5 | PO | 10 | 100 ± 16 × 103 | 15 ± 7 × 101 |
CAMB | 1 | PO | 10 | 503 ± 96 × 102 | 3 ± 5 × 101 (7) |
CAMB | 2.5 | PO | 10 | 26 ± 8 × 102 c,d | 0 |
CAMB | 5 | PO | 10 | 12 ± 6 × 102 c,d | 0 |
Trial 2 | |||||
Control | 0 | PO | 0 | 121 ± 48 × 105 | 172 ± 87 × 102 |
DAMB | 1 | IP | 7 | 496 ± 71 × 102 | 28 ± 57 × 102 (7) |
LAMB | 10 | PO | 9 | 275 ± 216 × 102 | 6 ± 7 × 101 (5) |
CAMB | 5 | PO | 10 | 13 ± 8 × 102 c,d (1) | 0 |
CAMB | 10 | PO | 10 | 28 ± 31 × 102 c,d | 0 |
CAMB | 20 | PO | 10 | 26 ± 48 × 102 c,d (2) | 0 |
Surviving animals, out of a total group of 10, on day 16.
Animals treated PO with empty cochleates.
P < 0.01 compared with results for the respective control mice.
P < 0.05 compared with results for the respective DAMB at 2 mg/kg/day.
Numbers in parentheses indicate the number of animals with undetectable colony counts.